Back

Scientist, Discovery Biology

Denali TherapeuticsDenali Therapeutics·Biotechnology

Compensation

$110,000 - $143,000/year

Apply effort

<60 sec

via Aplyr Quick Apply

Posted

18 days

01

About the role

Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.

We invite you to consider an opportunity with Denali to help achieve our goal of delivering meaningful therapeutics to patients.

Denali Therapeutics is seeking an outstanding biologist or neuroscientist to join our Discovery Biology group to support preclinical activities, with a focus on oligonucleotide therapeutic development and in vivo translational science. In this role, you will apply in vivo models, molecular and cellular assays, and pharmacokinetic and pharmacodynamic (PK/PD) studies to support target validation, biomarker discovery, and therapeutic development. You will work in close collaboration with colleagues in Preclinical Translational Sciences and Developmental Sciences to support the progression of Denali’s pipeline candidates through preclinical development.

Key Accountabilities / Core Job Responsibilities

  • Design and execute in vivo and ex vivo studies that inform candidate progression, PK/PD modeling, and biomarker strategies in alignment with clinical development objectives

  • Collaborate closely with Safety and DMPK scientists to support PK/PD analyses in preclinical models

  • Implement biochemical and molecular wet lab techniques (see below), including technical troubleshooting

  • Analyze and interpret experimental data, report quantitative results in a timely manner, and maintain clear and complete documentation using electronic lab notebooks

  • Communicate experimental designs and preclinical study results clearly to cross-functional teams and collaborators

  • Stay current on scientific literature and emerging technologies related to CNS drug delivery and disease research

Qualifications/Skills

  • PhD in Neuroscience, Cell Biology, Pharmacology, or a related scientific field OR Master’s degree and 3+ years of relevant experience in academia or pharmaceutical discovery/translational research

  • Technical proficiency in wet lab techniques, including RNA extraction, quantitative PCR, tissue sectioning, immunofluorescent staining, plate-based assays (such as ELISAs for protein quantification), microscopy, etc.  

  • Experience working with in vivo models and CNS tissue-based studies

  • Strong scientific reasoning as it pertains to experimental design and data analysis

  • Ability to work independently in a self-motivated fashion, and to maintain flexibility in a fast-paced research environment

  • Highly organized, with the ability to effectively prioritize individual tasks

  • Strong verbal and written communication skills 

  • Passion for applied neurodegeneration research and motivated to contribute to a mission-driven research environment

Salary Range: $110,000.00 to $143,000.00 .  Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Denali offers a competitive total rewards package, which includes a 401k, healthcare coverage, ESPP and a broad range of other benefits. Learn more at https://www.denalitherapeutics.com/careers

This compensation and benefits information is based on Denali’s good faith estimate as of the date of publication and may be modified in the future.
 

Denali is committed to its core company value of unity by creating a diverse and inclusive environment. We are proud to be an equal opportunity employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity and/or expression, status as a veteran, basis of disability, or any other federal, state, or local protected class.

02

Aplyr's read

Denali Therapeutics is a pioneering biotech firm tackling neurodegenerative diseases, attracting scientists passionate about cutting-edge neurological research.

Synthesized from recent postings & public sources

What's promising

  • Denali's focus on neurodegenerative diseases addresses a critical unmet medical need.
  • The company employs innovative approaches like blood-brain barrier technology.
  • Recent successful funding rounds provide financial stability for research initiatives.

What to watch

  • High-risk nature of biotech can lead to uncertain outcomes in drug development.
  • Regulatory hurdles in neurodegenerative therapies can delay product timelines.
  • Intense competition in the biotech space may impact market share.

Why Denali Therapeutics

  • Denali leverages proprietary Transport Vehicle technology for drug delivery.
  • The company has a strategic partnership with Biogen for Parkinson's therapies.
  • Denali's targeted approach focuses on genetically validated pathways.

Aplyr’s read is generated by AI from public sources. Was it useful?

03

About Denali Therapeutics

Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

04

Similar roles